Provided by Tiger Trade Technology Pte. Ltd.

Ardelyx

7.32
+0.32004.57%
Post-market: 7.390.0692+0.95%19:57 EST
Volume:3.18M
Turnover:22.98M
Market Cap:1.78B
PE:-31.00
High:7.34
Open:7.15
Low:6.99
Close:7.00
52wk High:8.40
52wk Low:3.21
Shares:242.97M
Float Shares:232.53M
Volume Ratio:0.95
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2361
EPS(LYR):-0.1664
ROE:-36.18%
ROA:-5.55%
PB:11.53
PE(LYR):-44.00

Loading ...

Ardelyx Inc. kündigt Veröffentlichung neuer Geschäftszahlen an

Reuters
·
Feb 05

Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026

GlobeNewswire
·
Feb 05

Ardelyx Granted New U.S. Patent Covering IBSRELA and XPHOZAH, Extending Protection to 2042

Reuters
·
Feb 03

Ardelyx Price Target Maintained With a $17.00/Share by BTIG

Dow Jones
·
Jan 29

BUZZ-Ardelyx rises as it begins late-stage test of constipation drug

Reuters
·
Jan 28

Ardelyx announces first patient dosed in ACCEL

TIPRANKS
·
Jan 28

Ardelyx Inc - Doses First Patient in Accel Phase 3 Trial

THOMSON REUTERS
·
Jan 28

Ardelyx Inc - Enrollment Expected Throughout 2026, Topline Data in 2027

THOMSON REUTERS
·
Jan 28

Ardelyx Launches Phase 3 ACCEL Trial of IBSRELA for Chronic Idiopathic Constipation

Reuters
·
Jan 28

U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings

Reuters
·
Jan 27

Ardelyx Is Maintained at Outperform by Wedbush

Dow Jones
·
Jan 21

Wedbush Raises Price Target on Ardelyx to $19 From $16, Keeps Outperform Rating

MT Newswires Live
·
Jan 21

Ardelyx, Inc. (NASDAQ:ARDX) Stock Catapults 37% Though Its Price And Business Still Lag The Industry

Simply Wall St.
·
Jan 21

U.S. RESEARCH ROUNDUP-IBM, KLA, WEX

Reuters
·
Jan 21

Market Chatter: Ardelyx May Be Acquired by Zydus Life

MT Newswires Live
·
Jan 21

Top Ardelyx Executive Executes Significant Stock Sale That Investors Can’t Ignore

TIPRANKS
·
Jan 10

Ardelyx Chief Patient Officer Laura A. Williams Reports Sale of Common Shares

Reuters
·
Jan 10

BUZZ-U.S. STOCKS ON THE MOVE-Broadcom, home lenders, First Solar

Reuters
·
Jan 09

Ardelyx Raised to Overweight From Neutral by Piper Sandler

Dow Jones
·
Jan 09

Piper Sandler Upgrades Ardelyx to Overweight From Neutral

MT Newswires Live
·
Jan 09